Polymorphisms of PTH (parathyroid hormone) gene and risk of kidney stone disease: A case-control study from West Bengal, India
Urology Jul 07, 2018
Mitra P, et al. - Authors gauged the potential contribution of PTH (parathyroid hormone) gene polymorphisms in kidney stone disease (KSD), a global clinical problem impacting major burden on public health care system worldwide. This first time report in the world regarding association of PTH gene polymorphisms with KSD suggested that for early detection of KSD and for preventing its occurrence, PTH gene polymorphisms could be used as potential genetic markers. Experts noted a significant association of the two single nucleotide polymorphisms (SNPs) (rs307247 and rs307248) of the 3’ UTR, which were in strong linkage disequilibrium with kidney stone risk in the population of West Bengal, India.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries